Medical device companies cannot measure commercial success through sales figures alone. A hospital purchasing a surgical navigation system does not guarantee that surgeons will adopt it, that the equipment will be used regularly, or that the installation will generate recurring revenue. The commercial opportunity extends well beyond the initial transaction.

This is where Medtech commercial analytics differs from pharmaceutical analytics. While pharma companies focus heavily on prescriptions, patient access and treatment adoption, medical device manufacturers must also understand procedure volumes, hospital purchasing decisions, equipment utilization, distributor performance and installed-base economics.

For Medtech companies, the real commercial question is not simply how many devices they sell, but how effectively those devices are adopted, utilized and monetized throughout their lifecycle.

How Is Medtech Commercial Analytics Different from Pharma?

Both industries use commercial analytics to understand markets, customers, sales performance and revenue opportunities. However, their demand drivers and purchasing dynamics require different analytical approaches.

DimensionPharma commercial analyticsMedtech commercial analytics
Demand measurementPrescriptions, patient starts and treatment volumesProcedure volumes, device usage and product consumption
Primary customershealthcare professionals (HCPs), patients, payers and healthcare organizationsHospitals, surgeons, procurement teams, distributors and integrated delivery networks (IDNs)
Purchasing decisionsInfluenced by prescribers, payers and formulariesOften involve clinicians, procurement, finance and value-analysis committees
Adoption measurementPrescription growth and treatment persistenceSurgeon adoption, procedure share and equipment utilization
Revenue modelPrimarily drug sales, including recurring treatment revenueCapital equipment, implants, consumables, services and software
Market opportunityEligible patient populations and treatment ratesAddressable procedures, facility coverage and installed-base potential

Five differences have particularly important commercial implications.

  • Prescription-driven vs. procedure-driven demand: Pharma companies use prescription and dispensing trends to understand product demand. Medtech manufacturers must examine how many relevant procedures are performed, which facilities perform them and which products are used during those procedures.
  • Individual HCP influence vs. institutional purchasing: A physician’s prescribing preference can significantly influence pharmaceutical demand. In Medtech, a surgeon may prefer a particular device, but hospital procurement, budget constraints, group purchasing organization (GPO) contracts and value-analysis committees can determine whether it is purchased.
  • Product adoption vs. device utilization: Prescription growth is a common signal of pharmaceutical adoption. In Medtech, an equipment sale is only the beginning. Actual usage, surgeon training and operating-room integration determine whether the product becomes part of routine clinical practice.
  • Single-product sales vs. multiple revenue streams: Medtech companies may generate revenue from equipment placements, implants, consumables, maintenance, software and upgrades. Commercial analytics must account for these interconnected revenue streams.
  • Patient access vs. institutional access: Pharma analytics examines payer coverage, formularies and affordability. Medtech analytics must additionally consider hospital procurement, capital budgets, tenders, reimbursement economics and contractual purchasing arrangements.

The distinction is important because a commercial model built primarily around HCP engagement and sales volume will overlook several critical drivers of medical device performance.

What Are the Biggest Commercial Analytics Challenges in Medtech?

Medtech companies frequently struggle to build a reliable picture of market demand and account performance because their commercial data is distributed across multiple stakeholders and systems.

Four challenges stand out.

  • Fragmented hospital and physician data: A hospital may operate under a larger IDN, purchase through a GPO and maintain separate facility-level procurement processes. Meanwhile, surgeons may work across multiple hospitals. Without consistent HCP and healthcare organization (HCO) identifiers, companies risk duplicating accounts or overlooking important relationships.
  • Limited competitor visibility: Manufacturers usually have detailed information about their own sales but less visibility into competitor performance. Procedure and claims data can help estimate market opportunity, but they do not always identify the exact device brand used. Consequently, reported sales cannot automatically be treated as accurate market share.
  • Distributor opacity: Manufacturer shipments to distributors do not necessarily reflect actual hospital purchases or product consumption. A temporary increase in distributor inventory can make demand appear stronger than it really is.
  • Complex procurement and contracting: Pricing agreements, GPO relationships, tender cycles, volume commitments and hospital budgets influence purchasing decisions. Commercial teams need visibility into these arrangements to understand why an account is growing, stagnating or switching suppliers.

These challenges make data integration essential. However, integration alone is not the objective. The real value comes from connecting commercial information to actual product adoption and revenue performance.

What Data Sources Do Medical Device Companies Need for Commercial Analytics?

A reliable Medtech commercial analytics model requires more than CRM and sales data. Companies need to connect information about customers, procedures, products, distribution and equipment performance.

The most important data sources include:

Data sourceCommercial application
CRM and HCP/HCO reference dataMap surgeons, hospitals, affiliations and account relationships
Medical claims and procedure dataEstimate procedure volumes and market opportunities
ERP and transaction dataTrack product sales, pricing, orders and revenue
Distributor dataMonitor sell-in, sell-through and channel inventory
Device utilization dataMeasure equipment usage and product adoption
Service and maintenance dataTrack uptime, downtime, service costs and customer experience
Contract dataMonitor pricing agreements, renewals and purchasing commitments

The challenge is connecting these datasets at the right level. For instance, procedure data might identify a hospital performing a high volume of orthopedic surgeries, while CRM data identifies the surgeons working there. Sales data reveals which implants the manufacturer has supplied, and distributor information provides additional visibility into product movement.

Together, these sources can help determine whether a hospital represents an untapped market opportunity, an underperforming account or an opportunity to expand an existing relationship.

However, data limitations must be acknowledged. Claims data does not always identify the specific device brand used, and not every manufacturer has access to distributor sell-through or real-time equipment utilization data.

IQVIA describes reference data, claims data and external sales data as important inputs for Medtech commercial applications.

How Can Medtech Companies Use Analytics to Improve Product Adoption and Revenue?

This is where Medtech commercial analytics creates value beyond conventional sales reporting.

Consider a medical device manufacturer selling advanced imaging equipment to hospitals. The initial sale generates capital revenue, but the equipment’s commercial potential extends throughout its operational life.

If a hospital purchases the equipment but uses it infrequently, the manufacturer may have secured the account without capturing its full commercial opportunity.

The same principle applies to surgical robotics, diagnostic systems, implant platforms and other technologies where adoption, utilization or recurring product consumption influence long-term revenue.

Why equipment placement does not guarantee product adoption

A device installation and its clinical adoption are two different milestones.

A hospital might purchase a robotic surgical system, but surgeons may continue using conventional surgical techniques because they lack training or confidence in the new technology. Operating-room scheduling, technical support and workflow integration can create additional barriers.

Sales reporting may classify the installation as a successful deal. Utilization analytics could reveal a different picture.

For example, imagine two hospitals that purchase identical surgical systems:

  • Hospital A performs 35 procedures per month.
  • Hospital B performs 12 procedures per month.

The difference does not automatically mean Hospital B is underperforming. Its patient volumes, clinical specialization, staffing and operating capacity may differ. However, the variation creates a reason to investigate adoption barriers and commercial potential.

Case support also affects adoption. Where trained clinical specialists or representatives support early procedures, adoption can progress faster, and analytics can test this by linking case-support activity to utilization.

Medtech companies can connect installation records, procedure volumes, equipment usage and training data to identify where additional clinical support or account engagement may be necessary.

How installed-base analytics can predict recurring revenue

An installed base represents the equipment currently deployed and operational across customer facilities.

For Medtech manufacturers, understanding this installed base is essential because it can generate revenue long after the initial equipment purchase.

Consider an imaging equipment manufacturer. Each installation may create opportunities for:

  • Maintenance and service contracts.
  • Replacement components and spare parts.
  • Software upgrades and subscriptions.
  • Consumables and accessories.
  • Equipment replacement and expansion.

The commercial opportunity is to connect equipment records with actual utilization, service history, purchasing behavior and contract information. Some manufacturers also use rental or usage-based contracts, where revenue follows utilization directly rather than the initial placement.

McKinsey research on medtech services highlights the growing importance of aftermarket services. Its analysis indicates that service-focused companies can generate up to 35% of revenue from services. It also finds that customers with paid service agreements demonstrate stronger brand loyalty and higher repurchase rates for products and related consumables.

This changes how commercial leaders should evaluate equipment sales.

Rather than measuring installations alone, they should examine:

MetricCommercial insight
Active installed baseNumber of operational devices generating potential revenue
Equipment utilizationWhether installations are being used effectively
Consumables revenue per deviceRecurring product revenue generated by each installation
Service contract attachmentOpportunity to monetize maintenance and support
Equipment agePotential replacement and upgrade demand
Service renewal rateCustomer retention and recurring revenue stability

Identifying underperforming accounts and expansion opportunities

Installed-base analytics also helps commercial teams distinguish between accounts that need additional support and accounts that are ready for expansion.

For example:

  • High installation, low utilization: Investigate training, workflow integration and clinical adoption.
  • High utilization, low consumables revenue: Examine product mix, purchasing arrangements and potential competitor usage.
  • High utilization, declining service performance: Prioritize maintenance and customer retention.
  • Aging equipment, high utilization: Evaluate replacement and upgrade opportunities.

This is a more actionable approach than simply ranking hospitals by annual revenue.

The underlying principle is that commercial analytics should connect product adoption with operational performance and future purchasing potential.

McKinsey has also published research on the digital and analytics priorities for B2B aftermarket growth, which is relevant to service revenue in Medtech.

How Can Commercial Analytics Improve Medtech Sales Forecasting and Performance Measurement?

Medtech forecasting requires different assumptions for different revenue streams. Treating equipment, consumables and services as one sales category can conceal important changes in underlying demand.

A more reliable approach separates forecasting into three components:

  • Capital equipment forecasting

Use hospital investment plans, equipment age, replacement cycles, tender pipelines and new facility openings to estimate future placements.

  • Consumables forecasting

Connect installed-base size with procedure volumes, device utilization and average consumables consumption per procedure.

  • Service and software forecasting

Use active equipment, service-contract attachment rates, renewal history, maintenance requirements and software subscriptions to estimate recurring revenue.

Commercial leaders should also distinguish manufacturer shipments from actual distributor sell-through and hospital consumption. Otherwise, excess channel inventory can distort demand projections.

The following KPIs help evaluate performance across these revenue streams:

KPIBusiness purpose
Procedure market penetrationMeasures product adoption across relevant procedures
Device utilization rateTracks actual equipment usage
Consumables revenue per deviceMeasures recurring monetization
Service contract attachment rateEvaluates service revenue opportunities
Account penetrationMeasures adoption across target accounts
Forecast accuracyEvaluates forecasting reliability

McKinsey’s analysis of more than 60 medtech companies found that those with the most advanced commercial capabilities had a CAGR 1.4 times higher than companies with average commercial capabilities. This reinforces the importance of building stronger commercial intelligence rather than relying on sales reporting alone.

How Can Medtech Companies Build a Unified Commercial Analytics Framework?

Building an effective analytics capability requires connecting commercial, clinical and operational information.

A practical implementation approach involves five steps:

  • Establish a unified data model: Standardize HCP, HCO, hospital, product and equipment identifiers.
  • Integrate relevant datasets: Connect CRM, ERP, claims, distributor, utilization and service information.
  • Standardize performance metrics: Establish consistent definitions for adoption, utilization, market penetration and recurring revenue.
  • Develop account-level intelligence: Combine procedure opportunities, purchasing behavior and installed-base performance.
  • Operationalize insights: Use analytics to prioritize sales activities, clinical support, service interventions and expansion opportunities.

The objective is not to build another dashboard. It is to give commercial teams a connected view of where opportunities exist, what prevents adoption and how existing customer relationships can generate additional revenue.

Conclusion

Medtech commercial analytics must extend beyond tracking sales and account acquisition. Manufacturers need to understand how devices are adopted, how frequently they are used, what recurring revenue they generate and when customers may require additional products or services. Connecting commercial, clinical and operational data makes this possible. Ultimately, the strongest Medtech analytics models measure not just what companies sell, but the commercial value generated throughout the product lifecycle.

Frequently Asked Questions

What is the difference between pharma and Medtech commercial analytics?

Pharma commercial analytics focuses primarily on prescriptions, patient adoption, treatment access and HCP engagement. Medtech commercial analytics additionally examines procedure volumes, hospital procurement, device utilization, installed-base performance, distributor activity and recurring service revenue.

Procedure-level data helps manufacturers estimate addressable demand, identify high-volume healthcare facilities and prioritize accounts. It provides a more meaningful measure of market opportunity than hospital counts alone, although claims data may not identify the specific device brand used.

Installed-base analytics examines equipment deployed across healthcare facilities, including its age, utilization, service history and recurring product consumption. It helps manufacturers identify replacement opportunities, improve service attachment and forecast revenue from existing customers.

Analytics connects procedure volumes, equipment placements, utilization, distributor inventory, consumables consumption and service contracts. This allows companies to forecast capital equipment, recurring product and service revenue using their respective demand drivers.

Useful KPIs include procedure volume, device utilization, consumables revenue per active device, service-contract attach and renewal rates, and distributor sell-through versus manufacturer shipments. Track them by revenue stream, since capital equipment, consumables, and service behave differently.

Link installation, training, and case-support activity to procedure volumes by account and surgeon to see where adoption stalls. Accounts with installed devices but low use usually need training, workflow integration, or clinical support rather than more sales effort.

Device utilization rate is how often an installed device is actually used, such as procedures per month per system. It matters because consumables and service revenue depend on usage, so a placement with low utilization can look like a sale but generate little recurring revenue.


Submit a Comment

Your email address will not be published. Required fields are marked *